PT  - JOURNAL ARTICLE
AU  - Joseph P. Kitzmiller
AU  - David K. Groen
AU  - Mitch A. Phelps
AU  - Wolfgang Sadee
TI  - Pharmacogenomic testing: Relevance in medical practice
AID  - 10.3949/ccjm.78a.10145
DP  - 2011 Apr 01
TA  - Cleveland Clinic Journal of Medicine
PG  - 243--257
VI  - 78
IP  - 4
4099  - http://www.ccjm.org/content/78/4/243.short
4100  - http://www.ccjm.org/content/78/4/243.full
SO  - Cleve Clin J Med2011 Apr 01; 78
AB  - Genetics may account for much of the variability in our patients’ responses to drug therapies. This article offers the clinician an up-to-date overview of pharmacogenomic testing, discussing implications and limitations of emerging validated tests relevant to the use of warfarin (Coumadin), clopidogrel (Plavix), statins, tamoxifen (Nolvadex), codeine, and psychotropic drugs. It also discusses the future role of pharmacogenomic testing in medicine.